These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20513005)
21. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis]. Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915 [No Abstract] [Full Text] [Related]
22. [Pharmacological treatment of the portal hypertension]. Castañeda Romero B Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863 [No Abstract] [Full Text] [Related]
23. [Medical therapy of portal hypertension due to liver cirrhosis]. Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876 [TBL] [Abstract][Full Text] [Related]
24. Carvedilol: the β-blocker of choice for portal hypertension? Bosch J Gut; 2013 Nov; 62(11):1529-30. PubMed ID: 23355548 [No Abstract] [Full Text] [Related]
25. Does losartan work after all? Blendis LM; Wong F Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261 [No Abstract] [Full Text] [Related]
27. How safe is carvedilol in NIDDM patients with hypertension? Choudhury D; Misra A Natl Med J India; 1998; 11(3):130-1. PubMed ID: 9707705 [No Abstract] [Full Text] [Related]
28. Losartan in preascitic cirrhosis. Castaño G; Viudez P; Sookoian S Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016 [No Abstract] [Full Text] [Related]
31. Influence of salt intake on the antihypertensive effect of carvedilol. Ruilope LM; Lahera V J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238 [TBL] [Abstract][Full Text] [Related]
36. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics. Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219 [TBL] [Abstract][Full Text] [Related]
37. Refining the Logic of Antihypertensive Therapy: An International Symposium on Carvedilol. Paris, France, October 19, 1990. J Hum Hypertens; 1993 Feb; 7 Suppl 1():S1-67. PubMed ID: 8098063 [No Abstract] [Full Text] [Related]